Phase II study of lenvatinib plus hepatic intra-arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma (LEOPARD trial)
Latest Information Update: 18 Nov 2021
At a glance
- Drugs Cisplatin (Primary) ; Lenvatinib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms LEOPARD
- 18 Nov 2021 New trial record
- 21 Sep 2021 Results presented at the 46th European Society for Medical Oncology Congress